Drugs of the Future Journal Citation Rate 2026

ISSN 0377-8282 eISSN 2013-0368 Thomson Reuters ES

About Drugs of the Future

{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Drugs of the Future (DF) is a peer-reviewed academic journal, published by Thomson Reuters in ES, catalogued under ISSN 0377-8282 (e-ISSN 2013-0368). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 0.00 — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model.

ISSN (Print)	0377-8282
ISSN (Online)	2013-0368
Publisher	Thomson Reuters
Country	Spain
APC / Cost	Inquire with Publisher

In-depth profile & metrics

Drugs of the Future is published by Thomson Reuters and based in Spain.

Drugs of the Future is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Links

Journal Homepage

Continue on JournalsHub

Put what you just read into practice with these free tools.

Citation Rate Checker

Verify IF, SJR quartile, CiteScore by ISSN.

Indexing Tracker

Confirm Scopus, DOAJ, JCR, OpenAlex status.

Compare Journals

Side-by-side metrics for up to 3 journals.

Find My Journal

Paste your abstract — get matched journals.

ABDC Journal List

Business / management A*, A, B, C tiers.

Browse All Journals

Search 6,300+ journals with full metrics.

Frequently Asked Questions about Drugs of the Future

No, Drugs of the Future is not an open access journal.

Drugs of the Future is published by Thomson Reuters.

Drugs of the Future shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Drugs of the Future is 0377-8282. Its electronic ISSN (eISSN) is 2013-0368.

Live Indexing Status

Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex

Verified

DOAJ

Non-OA

Predatory Check

Clean

Citation Rate

0.000

2-Year Citation Rate (OpenAlex) · 2025

Historical Trend

Initial data points only

Citation Rate by Year

Year	Value	Source
2025	0.000	2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Explore More Journals

Scopus Indexed Journals 2026 Q1/Q2 Rankings by Subject Open Call for Papers 2026 Browse All Journals

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S154339661

Get weekly updates

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Drugs of the Future Journal Citation Rate 2026

About Drugs of the Future

In-depth profile & metrics

Links

Continue on JournalsHub

Frequently Asked Questions about Drugs of the Future

Is Drugs of the Future open access?

Who publishes Drugs of the Future?

Is Drugs of the Future a legitimate (non-predatory) journal?

What is the ISSN of Drugs of the Future?